T. Rowe Price Investment Management, Inc.
Position in ASND — Ascendis Pharma A/S
CIK 1897612
BALTIMORE, MD
Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,409,443,866
+$1,053,839,511 QoQ
Shares Held
6,162,042
+269.5% QoQ
Ownership
9.39%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 95.49943022134546.ToString("F0")%
Shared 0.ToString("F0")%
None 4.500569778654544.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. ASND ranks #2 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,315,111 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
6,162,042 | $1,409,443,866 | |
| 3 | CYTK |
Cytokinetics Inc
|
17,523,840 | $1,154,996,294 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,033,823 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,642,847 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,146,572 | |
| 7 | BNTX |
BioNTech SE
|
5,856,073 | $520,487,768 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,481,337 |
All Filings in ASND
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-30 | $1,492,396,514 | 6,506,219 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $1,409,443,866 | 6,162,042 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $355,604,355 | 1,667,625 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $530,150,324 | 2,666,618 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $618,520,039 | 3,583,546 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $475,969,008 | 3,053,824 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $375,225,917 | 2,725,546 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $263,538,421 | 1,765,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,168,318 | 30,564 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $388,341,066 | 2,568,903 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $502,519,088 | 3,989,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $373,108,860 | 3,984,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $355,473,200 | 3,982,893 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $372,425,024 | 3,473,466 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $345,416,248 | 2,828,267 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $209,842,906 | 2,032,180 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||